MedTrace Logo

The Effects of tDCS Combined With rTMS on Post-stroke Cognitive Impairment

NCT06252987 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-02-12

No results posted yet for this study

Summary

If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\]

The purpose of the clinical trial is to find a treatment for stroke patients with cognitive impairment, and the main questions it aims to answer are:

* \[Search for effective treatments of cognitive impairment after stroke\]
* \[Explore brain network features with functional near-infrared spectroscopy\] Participants will receive conventional treatment, tDCS treatment, or rTMS treatment, or tDCS-rTMS treatment.

And then compare cognitive function and brain function.

Conditions

Interventions

OTHER

routine treatment

Routine medical treatment, basic rehabilitation training and individualized cognitive training

OTHER

Non-invasive brain stimulation

tDCS\&rTMS

Sponsors & Collaborators

  • The Second Affiliated Hospital of Dalian Medical University

    lead OTHER

Principal Investigators

  • Yongmei Jiang · Department of Rehabilitation Medicine, the Second Hospital of Dalian Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06252987 on ClinicalTrials.gov